TABLE 3.

Characteristics of patients with immune checkpoint inhibitor pneumonitis (n=200)

Grade
0	139 (69.5%)
1	10 (5.0%)
2	19 (9.5%)
3	23 (11.5%)
4	0 (0.0%)
5	9 (4.5%)
CT pattern (n=61)
OP pattern	29 (47.5%)
DAD pattern	19 (31.1%)
NSIP pattern	6 (9.8%)
HP pattern	3 (4.9%)
Others	4 (3.3%)
Medication (n=61)
Steroid	36 (59.0%)
Steroid pulse	17 (27.9%)
Misadministration of ICI	8 (13.1%)

CT: computed tomography; OP: organising pneumonia; DAD: diffuse alveolar damage; NSIP: nonspecific interstitial pneumonia; HP: hypersensitivity pneumonitis; ICI: immune checkpoint inhibitors.